FDA okays pre-approval study of Israeli cartilage implant
Some 250 patients to be enrolled in 2-year trial aimed to show superiority of cartilage-regenerating Agili-C implant over surgical standard of care.
Some 250 patients to be enrolled in 2-year trial aimed to show superiority of cartilage-regenerating Agili-C implant over surgical standard of care.
CartiHeal, developer of a novel joint-repair solution, raises $15m investment to advance clinical trials ahead of 2017 European launch.